Reagents and instruments for immunology, cell biology and molecular biology.
 
> Protease Inhibitor Cocktail, mini-Tablet

Protease Inhibitor Cocktail, mini-Tablet

Print Print
Please log in

Cat# HY-K0011-50pcs

Size : 50pcs

Brand : MedChemExpress

Protease Inhibitor Cocktail, mini-Tablet

Protease Inhibitor Cocktail, mini-Tablet  (EDTA-Free)

Cat. No.: HY-K0011
Manual COA SDS

Protease inhibitor cocktail is used in cell lysates or tissue extracts to increase protein stability.

Protease Inhibitor Cocktail, mini-Tablet
or

*

Protease Inhibitor Cocktail, mini-Tablet Featured Recommendations:

  • Protease Inhibitor Cocktail
  • Phosphatase Inhibitor Cocktail I
  • Phosphatase Inhibitor Cocktail II
  • Phosphatase Inhibitor Cocktail III
  • Deacetylase Inhibitor Cocktail (100× in 70% DMSO)
  • Protein A/G Magnetic Beads
  • Magnetic Stand
  • Anti-HA Magnetic Beads
  • Streptavidin Magnetic Beads
  • Protein A Magnetic Beads

  • Description

  • Storage

  • Protocol

  • Components

  • Documentation

Endogenous proteins are produced and removed in a balanced state, so their cellular levels are generally stable under stable environmental conditions. However, protein production is greatly halted and degradation is enhanced when cells are studied in vitro. To prevent the degradation of proteins under such conditions, one can utilize a cocktail of small molecule inhibitors to block the action of proteases. Generally, protease inhibitor cocktails are used in cell lysates or tissue extracts to increase protein stability. As the name indicates, the cocktail functions to inhibit proteases that would degrade either phosphorylated or non-phosphorylated protein substrates. MedChemExpress Protease Inhibitor Cocktail (EDTA free, mini-Tablet) is a blend of 5 pan-protease inhibitors for protection of protein integrity.
  • •Cell. 2020 Apr 30;181(3):621-636.e22.  [Abstract]
  • •Cell Res. 2021 Mar;31(3):345-361.  [Abstract]
  • •Signal Transduct Target Ther. 2021 Sep 4;6(1):333.  [Abstract]
  • •Cell Discov. 2021 Jun 22;7(1):46.  [Abstract]
  • •Sci Immunol. 2022 Feb 4;7(68):eabk2092.  [Abstract]
  • •Cell Mol Immunol. 2021 Mar 11.  [Abstract]
  • •Nat Metab. 2023 May 15.  [Abstract]
  • •Adv Funct Mater. 2020, 2004886.
  • •Adv Sci (Weinh). 2022 Oct 30;e2204697.  [Abstract]
  • •Nucleic Acids Res. 2023 Mar 20;gkad197.  [Abstract]
  • •Acta Pharm Sin B. 2021 Jun;11(6):1592-1606.  [Abstract]
  • •Acta Pharm Sin B. 2020 Dec 15.
  • •Cell Rep Med. 2022 Mar 15;3(3):100561.  [Abstract]
  • •Cell Rep Med. April 20, 2022.
  • •J Hazard Mater. 5 October 2022, 129689.
  • •Sci Adv. 2021 Mar 3;7(10):eabe8591.  [Abstract]
  • •Engineering. 14 August 2021.
  • •Mol Ther. 2021 Jun 7;S1525-0016(21)00312-9.  [Abstract]
  • •Theranostics. 2021 Mar 4;11(10):4825-4838.  [Abstract]
  • •Theranostics. 2021 Jan 1;11(2):925-940.  [Abstract]
  • •Theranostics. 2020 Oct 30;10(26):12223-12240.  [Abstract]
  • •Theranostics. 2020 Aug 2;10(21):9830-9842.  [Abstract]
  • •Theranostics. 2020 Jul 11;10(19):8834-8850.  [Abstract]
  • •Environ Int. 2020 Aug;141:105755.  [Abstract]
  • •EMBO J. 2021 May 19;e106183.  [Abstract]
  • •J Exp Clin Cancer Res. 2020 Oct 21;39(1):222.  [Abstract]
  • •EMBO Mol Med. 2020 Dec 7;e12798.  [Abstract]
  • •J Colloid Interf Sci. 2021 May 24.
  • •Cancer Lett. 20 October 2021.
  • •ACS Appl Mater Interfaces. 2020 Oct 21;12(42):47330-47341.  [Abstract]
  • •New Phytol. 2021 May 27.  [Abstract]
  • •Pharmacol Res. 2023 Apr 15;106773.  [Abstract]
  • •J Neuroinflammation. 2020 May 6;17(1):150.  [Abstract]
  • •Int J Biol Sci. 2021 Mar 21;17(5):1234-1249.  [Abstract]
  • •Int J Biol Sci. 2021 Jan 1;17(1):339-352.  [Abstract]
  • •Cell Death Dis. 2021 Jun 2;12(6):570.  [Abstract]
  • •Cell Death Dis. 2021 Mar 17;12(4):284.  [Abstract]
  • •Cell Death Dis. 2020 May 11;11(5):351.  [Abstract]
  • •Environ Pollut. 2022 Oct 17;120446.  [Abstract]
  • •Cell Rep. 2023 Jun 22;42(7):112691.  [Abstract]
  • •Cell Rep. 2021 Nov 16;37(7):110025.  [Abstract]
  • •Chemosphere. 2021 Jan;262:127891.  [Abstract]
  • •Cell Rep. 2019 Jun 18;27(12):3684-3695.e4.   [Abstract]
  • •Hortic Res. 2023 May 4.
  • •Cell Prolif. 2021 May 5;e13045.  [Abstract]
  • •Cell Prolif. 2021 Apr 8;e13039.  [Abstract]
  • •Cell Commun Signal. 2021 May 20;19(1):58.  [Abstract]
  • •JCI Insight. 2022 Feb 22;7(4):e149626.  [Abstract]
  • •Phytomedicine. 2020, Jul 28.
  • •Cell Biosci. 2021 Jun 30;11(1):118.  [Abstract]
  • •Biomed Pharmacother. 2020 Aug;128:110216.  [Abstract]
  • •J Transl Med. 2021 Sep 20;19(1):396.  [Abstract]
  • •Free Radic Biol Med. 2021 Jan 12;S0891-5849(20)32114-6.  [Abstract]
  • •J Med Chem. 2022 Aug 31.  [Abstract]
  • •Mol Ther-Nucl Acids. 2020 Oct 4;22:708-721.  [Abstract]
  • •Cell Death Discov. 2021 Jan 11;7(1):3.  [Abstract]
  • •Antioxidants. 2020 Aug 22;9(9):780.  [Abstract]
  • •Eur J Med Chem. 2021, 113605.
  • •PLoS Pathog. 2020 Oct 16;16(10):e1009002.  [Abstract]
  • •Biomater Sci. 2021 May 10.  [Abstract]
  • •J Invest Dermatol. 2021 Sep 14;S0022-202X(21)01672-9.  [Abstract]
  • •Neural Regen Res. 2021 Jul;16(7):1308-1316.  [Abstract]
  • •Life Sci. 2020 Oct 15;259:118159.  [Abstract]
  • •Talanta. 2020 Nov 1;219:121281.  [Abstract]
  • •Cells. 2022 Nov 14;11(22):3602.  [Abstract]
  • •Cells. 2022 Feb 26;11(5):817.  [Abstract]
  • •Cells. 2022, 11(3), 447.
  • •Commun Biol. 2021 Jun 23;4(1):777.  [Abstract]
  • •Commun Biol. 2021 Apr 22;4(1):491.  [Abstract]
  • •iScience. 2023 Jul 27.
  • •iScience. 2022 Mar 1;25(4):104009.  [Abstract]
  • •Acs Biomater Sci Eng. 2021 Jun 30.  [Abstract]
  • •iScience. 2021, 102770.
  • •Biochem Pharmacol. 2021, 114542.
  • •Clin Epigenetics. 2021 Jun 10;13(1):127.  [Abstract]
  • •Cancer Sci. 2020 Nov;111(11):4142-4153.  [Abstract]
  • •Cancer Sci. 2020 Nov;111(11):4102-4117.  [Abstract]
  • •Am J Chin Med. 2020;48(6):1369-1383.  [Abstract]
  • •J Cell Physiol. 2023 Feb 15.  [Abstract]
  • •Int J Mol Sci. 2022 May 9;23(9):5259.  [Abstract]
  • •Int Immunopharmacol. 2021 Dec 16;103:108430.  [Abstract]
  • •Int J Mol Sci. 2021 Aug 26;22(17):9245.  [Abstract]
  • •Front Pharmacol. 24 June 2021.
  • •J Cell Physiol. 2021 May 27.  [Abstract]
  • •Int Immunopharmacol. 2021, 107785.
  • •Front Pharmacol. 20 May 2021.
  • •Int Immunopharmacol. 2021, 107342.
  • •Front Cell Dev Biol. 2021 Jul 8;9:689727.  [Abstract]
  • •J Virol. 2021 May 19;JVI.00563-21.  [Abstract]
  • •J Ethnopharmacol. 2021 Apr 20;114061.  [Abstract]
  • •Int J Mol Med. 2021 Jan;47(1):171-182.  [Abstract]
  • •Pharmaceutics. 2020 Oct 9;12(10):950.  [Abstract]
  • •Int J Mol Med. 2020 Aug;46(2):718-728.  [Abstract]
  • •Am J Cancer Res. 2021 Mar 1;11(3):930-944.  [Abstract]
  • •Bioorg Chem. May 2022, 105714.
  • •Bioorg Chem. 2021 Aug;113:104981.  [Abstract]
  • •Inflammation. 2020 Oct;43(5):1862-1875.  [Abstract]
  • •Inflammation. 2020 Oct;43(5):1772-1779.  [Abstract]
  • •J Mol Cell Cardiol. 2020 Dec;149:82-94.  [Abstract]
  • •J Drug Deliv Sci Technol. 2020, 102048.
  • •ACS Chem Neurosci. 2020 Jun 3;11(11):1682-1691.  [Abstract]
  • •Zool Res. 2020 Sep 18;41(5):527-538.  [Abstract]
  • •Chem Commun (Camb). 2020 Jan 30;56(9):1389-1392.  [Abstract]
  • •J Biol Chem. 2023 Apr 17;104723.  [Abstract]
  • •FASEB J. 2022 Feb;36(2):e22124.  [Abstract]
  • •J Biol Chem. Jan-Jun 2021;296:100614.  [Abstract]
  • •J Biol Chem. 2021, 100616.
  • •J Biol Chem. 2021 Feb 2;100369.  [Abstract]
  • •Drug Des Devel Ther. 2020 May 18;14:1897-1908.  [Abstract]
  • •Viruses. 2022, 14(11), 2349.
  • •Viruses. 2022, 14(3), 514.
  • •Viruses. 2022 Feb 15;14(2):394.  [Abstract]
  • •Viruses. 2020 Sep 2;12(9):974.  [Abstract]
  • •J Fungi (Basel). 2020 Jun 3;6(2):77.  [Abstract]
  • •Molecules. 2021, 26(6), 1580.
  • •Sci Rep. 2020 Aug 3;10(1):13063.  [Abstract]
  • •Eur J Pharm Sci. 2020 Aug 1;151:105402.  [Abstract]
  • •J Drug Target. 2020 May 4:1-26.  [Abstract]
  • •J Proteome Res. 2023 Jun 7.  [Abstract]
  • •Reprod Biol Endocrinol. 2022 Feb 2;20(1):25.  [Abstract]
  • •Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):48.  [Abstract]
  • •Regen Ther. 2020 Oct 16;15:202-209.  [Abstract]
  • •Neurochem Int. 2021, 105152.
  • •Oncol Rep. 2021 Apr 13.
  • •Neurobiol Aging. 2021 Feb;98:10-20.  [Abstract]
  • •Mol Cell Endocrinol. 2021 Feb 23;111218.  [Abstract]
  • •Cancer Med. 2021 May 7.  [Abstract]
  • •Cancer Med. 2021 Apr;10(7):2470-2481.  [Abstract]
  • •Breast Cancer. 2021 Jul;28(4):859-873.  [Abstract]
  • •J Cancer. 2021 Apr.
  • •BMC Complement Med Ther. 21, 88 (2021).
  • •Placenta. 2022 Jan 10;118:55-65.  [Abstract]
  • •J Gen Virol. 2020 Nov;101(11):1145-1155.  [Abstract]
  • •Mol Brain. 2022 Jan 3;15(1):4.  [Abstract]
  • •Neurotoxicology. 28 October 2022.
  • •Mol Med Rep. 2021 Aug;24(2):580.  [Abstract]
  • •Brain Sci. 2023, 13(2), 262.
  • •Vet Microbiol. 2020 Jun;245:108709.  [Abstract]
  • •Vet Microbiol. 2020 Jun;245:108707.  [Abstract]
  • •Toxicol In Vitro. 2020 Jun;65:104825.  [Abstract]
  • •Dig Dis Sci. 2022 Jun;67(6):2220-2231.  [Abstract]
  • •Biochem Biophys Res Commun. 2021 Apr 8;556:127-133.  [Abstract]
  • •Infect Immun. 2021 Feb 1;IAI.00696-20.  [Abstract]
  • •Biochem Biophys Res Commun. 2021 Feb 3;545:105-111.  [Abstract]
  • •Infect Immun. 2020 Oct 19;88(11):e00537-20.  [Abstract]
  • •Biochem Bioph Res Co. 2020 Sep 10;530(1):160-166.  [Abstract]
  • •Biochem Bioph Res Co. 2020 Jul 30;528(3):485-492.  [Abstract]
  • •Biochem Biophys Res Commun. 2020 Jul 12;528(1):105-111.  [Abstract]
  • •Insects. 2021, 12(9), 812.
  • •Oncol Lett. 2021 Feb;21(2):117.  [Abstract]
  • •Mol Biol Rep. 2021 May 18.  [Abstract]
  • •Theriogenology. 2021 Mar 19.
  • •J Orthop Surg Res. 2021 May 5;16(1):297.  [Abstract]
  • •Xenobiotica. 2021 Aug 12;1-25.  [Abstract]
  • •J Interv Card Electrophysiol. 2021 Feb 20.  [Abstract]
  • •Protein Expres Purif. 2021, 105860.
  • •Acta Neurobiol Exp. 2022, 82.
  • •J Gen Appl Microbiol. 2021 Apr 16;67(1):33-41.  [Abstract]
  • •Int J Med Mushrooms. 2020;22(10):979-990.  [Abstract]
  • •bioRxiv. 2023 Aug 15.
  • •Research Square Preprint. 2023 Jun 21.
  • •Research Square Preprint. 2022 May.
  • •Research Square Preprint. 2022 Feb.
  • •Leuk Res. December 2021, 106708.
  • •Research Square Preprint. 2021 Aug.
  • •Health Sci J. (2021): 1-7.
  • •Methods Mol Biol. 2021;2348:231-242.  [Abstract]
  • •Exp Hematol Oncol. 2021 Jun 4;10(1):35.  [Abstract]
  • •Research Square Preprint. 2021 Jun.
  • •Research Square Preprint. 2021 May.
  • •Biomed Res Int. 2021 Apr 16.
  • •Bezmialem Science. 2021;9(2):164-70.
  • •Research Square Preprint. 2021 Mar.
  • •Research Square Preprint. 2021 Mar.
  • •SSRN. 2021 Jan 26.
  • •Mediat Inflamm. 2020 Oct 15;2020:4346367.  [Abstract]
  • •Research Square Preprint. 2020 Dec.
  • •Research Square Preprint. 2020 Oct.
  • •Preprints. 2020, 2020090120.
  • •Research Square Preprint. 2020 Sep.
  • •Evid Based Complement Alternat Med. 2020 Oct 30;2020:8894257.  [Abstract]
  • •bioRxiv. 2020 Jul.
Protease Inhibitor Cocktail (EDTA free, mini-Tablet) can be stored at 4°C for 2 years.

1. This product can be applied in Western Blot analysis, Co-IP, pull-down, IF, IHC, kinase assay and etc.
2. One mini-Tablet can be added to 10mL extraction medium directly. Alternatively, a stock solution (10X conc. one mini-Tablet in 1mL ddH2O) can be prepared. Vortex briefly to accelerate the dissolution. The stock solution is stable for one week when stored at 4°C, and for at least 4 weeks at -20°C.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Bulk Inquiry

Your information is safe with us. * Required Fields.

Bulk Inquiry

Inquiry Information

Product Name:
Protease Inhibitor Cocktail, mini-Tablet
Cat. No.:
HY-K0011
Quantity:
MCE Japan Authorized Agent:

You might also be interested by the following products:



Cat#
Description
Cond.
Price Bef. VAT